Navigation Links
Generic prostate drug helps find high-risk cancers early
Date:9/11/2007

ANN ARBOR, Mich. Men now have another good reason to consider taking finasteride, a well-known generic drug that shrinks an enlarged prostate and reduces the risk of getting prostate cancer by 25 percent. A new study from the Southwest Oncology Group strongly suggests that for men at risk of the disease which strikes one in six men finasteride also raises the odds that physicians will find fast-growing prostate cancers early, when they are most easily treatable.

It appears that a man concerned about prostate-cancer risk, who is having a PSA test on a regular basis, will not only reduce his risk of prostate cancer if he takes finasteride, but will help find the cancers that pose the highest risk, says Ian M. Thompson, M.D., the studys senior author and a urologist at the University of Texas Health Science Center in San Antonio.

The new results, embargoed until 4 p.m. Sept. 11, appear online ahead of print publication Sept. 18 in the Journal of the National Cancer Institute.

"This report provides an important interpretation of results that confounded an overall favorable interpretation of the Prostate Cancer Prevention Trial initially, and should help lessen fears that finasteride somehow causes more aggressive prostate cancer, says Frank L. Meyskens, Jr., M.D., Southwest Oncology Group associate chair for cancer control and prevention.

The Southwest Oncology Group (SWOG), headquartered at the University of Michigan and one of the nations largest National Cancer Institute-sponsored clinical trial networks, conducted the study to further analyze data from its National Cancer Institute-sponsored 18,882-man seven-year Prostate Cancer Prevention Trial, which in 2003 found that finasteride was an effective prevention agent. The Food and Drug Administration has not approved finasteride for use in cancer prevention; the drug is approved for treating enlarged prostate.

Four years ago, Southwest Oncology Group researche
'/>"/>

Contact: Anne Rueter
arueter@umich.edu
734-764-2220
University of Michigan Health System
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Generic drug costs remain shackled
2. FDA Approves Indian Generic Drug For AIDS Treatment
3. Proper Validation of Generic Drugs Could Save Millions of AIDS Patients
4. AIDS Generic Drugs Approved by FDA for Sale in US
5. HIV Mortality declining in India due to Generic Antiretroviral therapy drugs
6. Generic Drugs Usage In US Can Save $20 Billion – Express Script Surve
7. India to produce Tamiflu generic ‘Oseltamivir
8. US FDA approved Aurobindo Pharma to produce generic AIDS drug
9. Generic Products Compete With GlaxoSmithKline
10. ViroPharma Shares Fall As FDA Moves Towards Generic Vancocin
11. Ranbaxy Expands By Acquiring A Generic Company In Belgium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... “In the current environment of ... regulations, we provide education that will help practitioners ... suffering from pain, within the boundaries of the ... of rehabilitation medicine and President/Medical Director of the ... , A new flight of PAINWeekEnd Regional Conferences ...
(Date:5/29/2015)... Ready to hit the road? Before embarking on a big ... vehicles ready. With handicapped vehicles, there are even more things ... ready to help drivers get their handicapped vans ready by ... When planning for the big trip, drivers should be sure ... smoothly and they are prepared for all contingencies: , ...
(Date:5/29/2015)... The science of hair restoration has taken ... the efforts of internationally recognized hair transplant surgeon Dr. ... hair restoration and manual FUE techniques to offer ... , A Follicular Unit Extraction (FUE) is ... grafts from the donor areas of a patient. ...
(Date:5/29/2015)... 2015 The third annual Newport 10 ... closed to new registration, starts outside the east wall ... competitive running event demonstrates the power of combining professional ... benefit – in this case, historic preservation. , ... famed Ocean Drive and passes by many Bellevue Avenue ...
(Date:5/29/2015)... Abinton, PA (PRWEB) May 29, 2015 ... selected to be among the first hospitals in ... to enhance maternity care practices and work ... is a hospital-based quality-improvement initiative focusing on maternity ... the Centers for Disease Control and Prevention, EMPower ...
Breaking Medicine News(10 mins):Health News:PAINWeekEnd Kansas City: Pain Management CME for the Main Street Practitioner 2Health News:Advanced Driving Systems Offers Tips for Summer Road Trips 2Health News:Advanced Driving Systems Offers Tips for Summer Road Trips 3Health News:Los Angeles and Beverly Hills Hair Transplant Doctor Now Combines Robotic Hair Restoration (ARTAS) and Manual FUE Transplants for Maximum Hair Coverage 2Health News:The Newport 10 Miler at Fort Adams, an Outstanding Example of Event Marketing Helping in Preservation, is Now Completely Booked for 2015 2Health News:The Newport 10 Miler at Fort Adams, an Outstanding Example of Event Marketing Helping in Preservation, is Now Completely Booked for 2015 3Health News:Abington Hospital Selected to Join Baby-Friendly Hospital Initiative 2
... than pills, whenever possible, , MONDAY, March 29 (HealthDay ... but that daily multivitamin pill, calcium supplements and possibly ... say that getting crucial nutrients from food, when possible, ... Association, in fact, has updated its guidelines on nutrient ...
... team at the Sahlgrenska Academy at the University of Gothenburg, ... enzymes could be targets for the treatment of lung cancer. ... of the two enzymes in transgenic mice. This resulted in ... the mice. The article is being published in the ...
... release is available in Spanish . , ... fat and fewer calories, thanks to work by Agricultural ... based at the ARS National Center for Agricultural Utilization ... her Peoria laboratory, Singh is formulating low-fat cake mixes ...
... ... – including a “Describe How You Feel” tool – to help patients put their symptoms ... ... are now available on www.letstalkibs.com to help patients living with irritable bowel ...
... ... help make moving easy. , ... (PRWEB) March 29, 2010 -- On March 8, Barrett Moving & Storage ... grown moving company’s multiple service areas—including various household moves, corporate relocations, high value shipments ...
... ... product development. , ... Toronto, ON (Vocus) March 29, 2010 -- Therapure Biopharma Inc. today announced a fill/finish ... Under the terms of the agreement, Therapure will provide custom fill/finish services for a ...
Cached Medicine News:Health News:To Supplement or Not to Supplement? 2Health News:To Supplement or Not to Supplement? 3Health News:Promising strategy for treatment of lung cancer 2Health News:LetsTalkIBS.com Helps Patients Start the Conversation about Irritable Bowel Syndrome 2Health News:Minnesota Moving Company, Barrett Moving & Storage Launches New Online Look at www.barrettmoving.com 2Health News:Therapure Biopharma Inc. signs fill/finish contract with Kane Biotech Inc. 2
(Date:5/29/2015)... , May 29, 2015 LifeNet Health plans ... hiring for 2015 to more than 160 people. ... demand for LifeNet Health,s innovative bio-implants, which are being ... patients to be served. It also is a reflection ... "The growth and success of LifeNet Health ...
(Date:5/29/2015)... and MENLO PARK, Calif. ... DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ("DelMar" and ... and commercializing proven cancer therapies in new orphan ... American Association of Cancer Research (AACR) Advances ... potential for its lead product candidate VAL-083 ...
(Date:5/29/2015)... Educating the community continues to be ... Advancement of Wound Care (AAWC), which was incorporated ... corporate partners, the Association provides medical professionals with ... website at http://aawconline.org/education-for-the-generalist/ . The portal is ... to various CME/CEU educational programs. This education is ...
Breaking Medicine Technology:LifeNet Health to add more than 160 jobs in 2015 2DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 2DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 3DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 4DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 5The Association for the Advancement of Wound Care Educates the Public 2
... Md., Nov. 7, 2011 The U.S. Food and ... chemotherapy to treat patients with late-stage (metastatic) head and ... Combined with chemotherapy, Erbitux extended the ... those receiving chemotherapy alone. Erbitux already is FDA-approved for ...
... 2011 MAQUET Cardiovascular, a global leading provider ... received U.S. Federal Trade Commission (FTC) approval to ... device technologies for interventional cardiology and radiology, chest ... general surgery, and has subsequently closed the previously ...
Cached Medicine Technology:FDA Approves Erbitux to Treat Late-stage Head and Neck Cancer 2FDA Approves Erbitux to Treat Late-stage Head and Neck Cancer 3MAQUET Cardiovascular Completes Acquisition of Atrium Medical Corporation 2MAQUET Cardiovascular Completes Acquisition of Atrium Medical Corporation 3
... a robust and durable drainage system. Preplaced ... globe. Pressure Ridge Molteno Implants have a ... tissue, acts as a Pressure sensitive biological ... implants allows the surgeon to choose the ...
... a low implant profile, 0.84mm, for better ... insertion is technically simpler and allows a ... installed with less trauma than multiple quadrant ... implant were designed to minimize bleb height ...
1-Meter Roll-Up Tangent Screen....
... accurate detections of any ... as glaucoma in the ... performed. Smooth operation of ... High accuracy of static ...
Medicine Products: